Evidence map›Paper›PMID 24818067›Full record

ArticleMobile genetic elements2014

L1 retrotransposition: The snap-velcro model and its consequences.

Sébastien Viollet, Clément Monot, Gaël Cristofari

Abstract read
In one paragraph

Article in Mobile genetic elements, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Structural and Mechanistic Diversity of Constitutional Chromoanagenesis.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. piRNA involvement in genome stability and human cancer.Journal of hematology & oncology · 2015
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sébastien ViolletINSERM; U1081; Institute for Research on Cancer and Aging of Nice (IRCAN); Nice, France ; CNRS; UMR 7284; Institute for Research on Cancer and Aging of Nice (IRCAN); Nice, France ; University of Nice-Sophia Antipolis; Faculty of Medicine; Nice, France.
Clément MonotINSERM; U1081; Institute for Research on Cancer and Aging of Nice (IRCAN); Nice, France ; CNRS; UMR 7284; Institute for Research on Cancer and Aging of Nice (IRCAN); Nice, France ; University of Nice-Sophia Antipolis; Faculty of Medicine; Nice, France.
Gaël CristofariINSERM; U1081; Institute for Research on Cancer and Aging of Nice (IRCAN); Nice, France ; CNRS; UMR 7284; Institute for Research on Cancer and Aging of Nice (IRCAN); Nice, France ; University of Nice-Sophia Antipolis; Faculty of Medicine; Nice, France.

Funding

European Research Council 243312
6 · The paper itself

Abstract

LINE-1 (L1) elements are the only active and autonomous transposable elements in humans. The core retrotransposition machinery is a ribonucleoprotein particle (RNP) containing the L1 mRNA, with endonuclease and reverse transcriptase activities. It initiates reverse transcription directly at genomic target sites upon endonuclease cleavage. Recently, using a direct L1 extension assay (DLEA), we systematically tested the ability of native L1 RNPs to extend DNA substrates of various sequences and structures. We deduced from these experiments the general rules guiding the initiation of L1 reverse transcription, referred to as the snap-velcro model. In this model, L1 target choice is not only mediated by the sequence specificity of the endonuclease, but also through base-pairing between the L1 mRNA and the target site, which permits the subsequent L1 reverse transcription step. In addition, L1 reverse transcriptase efficiently primes L1 DNA synthesis only when the 3' end of the DNA substrate is single-stranded, suggesting so-far unrecognized DNA processing steps at the integration site.

Indexed as

endonucleaseL1LINE-1non-LTR retrotransposonpoly(A) tailreverse transcriptasereverse transcriptiontarget-primed reverse transcriptionTPRT

Identifiers

PMID24818067
PMCPMC4014453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.